Some advanced epithelial ovarian cancer patients can avoid a lymphadenectomy without impacting survival outcomes

Immunotherapy promise for gynaecologic extra-renal clear cell carcinomas

Monitoring ovarian function in oncology studies

Mirvetuximab soravtansine and pembrolizumab combo shows promise in endometrial cancer subtype

Cancer personomics: Launching the missile - Localised endometrial carcinoma.

Novel therapies and combinations in ovarian cancer

The treatment of cervical cancer in the presence of HIV in Sub-Saharan Africa

The Lancet Commission on women, power, and cancer: Patient Stories

Gender inequity in ovarian cancer research in resource limited settings

Synthetic biology and precision medicine in blood and gynaecological cancers

Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours

First-line chemotherapy with atezolizumab and bevacizumab significantly improves survival for R/M cervical cancer